Home   >  
GPCR/G Protein
Angiotensin Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Angiotensin Receptor

Chemical Structure Cat. No. Product Name CAS No.
Sparsentan Chemical Structure
BCP23969 Sparsentan 254740-64-2
Sparsentan is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively.
BMS-346567 Chemical Structure
BCP41192 BMS-346567 953807-31-3
BMS-346567 is apotent and selective dual angiotensin II and endothelin A receptor antagonist.
Fimasartan Potassium Trihydrate Chemical Structure
BCP32997 Fimasartan Potassium Trihydrate 1020110-23-9
Fimasartan is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure.
AT2 Agonist C21 Chemical Structure
BCP30872 AT2 Agonist C21 477775-14-7
AT2 Agonist C21 is the first potent and selective agonist of angiotensin AT2 receptors, preventing endothelial inflammation and leukocyte adhesion in vitro and in vivo.
N-Trityl candesartan ethyl ester Chemical Structure
BCP08526 N-Trityl candesartan ethyl ester 856414-35-2
Candesartan analog as angiotensin II antagonist.
Trityl candesartan Chemical Structure
BCP12746 Trityl candesartan 139481-72-4
Candesartan analog as angiotensin II antagonist
Azilsartan kamedoxomil Chemical Structure
BCP11249 Azilsartan kamedoxomil 863031-24-7
Azilsartan Kamedoxomil is an azilsartan prodrug and angiotensin II type 1 receptor blocker used for the treatment of hypertension.
Losartan Carboxylic Acid Chemical Structure
BCP08038 Losartan Carboxylic Acid 124750-92-1
EXP-3174, also known as Losartan Carboxylic Acid, is a physiologically active metabolite of losartan, produced by cytochrome P450 isoforms in the liver.
Ang II Chemical Structure
BCP24777 Ang II 4474-91-3?
Angiotensin II human is a vasoconstrictor that acts on the AT1 and the AT2 receptor.
Olodanrigan Chemical Structure
BCP23998 Olodanrigan 1316755-17-5
Olodanrigan, also known as EMA-401 and PD-126055, is an angiotensin AT2 antagonist potentially for treatment of postherpetic neuralgia (PHN).
123下一頁末頁共 47 條記錄 1 / 5 頁 
<蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>